PRDM9 and cancer: While a great deal remains to be learned regarding the precise underlying mechanisms in KC pathogenesis, current evidence from a variety of cancers suggests that histone methyltransferase function may impact an array of different processes ranging from differentiation and DNA repair to metabolism and programmed cell death.